 - Receipt of any of the following treatments within 4 weeks prior to study entry: chemotherapy within 6 weeks for nitrosurea or mitomycin C, radiotherapy, hormone therapy except for androgen-deprivation therapy for patients with prostate cancer, immunotherapy and any other anti-cancer therapies. 